Dissociation of the hepatic phenotype from HNF4 and HNF1alpha expression.

Biosci Rep

Department of Biological Sciences, Eastern Illinois University, 600 Lincoln Avenue, Charleston, IL, 61920, USA.

Published: December 2004

Dedifferentiated cells have served as tools to understand the molecular consequences of the loss of tissue-specific pathways. Here we report the characterization of one of these cell lines, M29, which lacks the liver-enriched HNF4-HNF1alpha pathway, in order to determine if this class of variant cell lines could provide additional information regarding requirements for tissue-type expression. We report that although the liver-specific alpha1-antitrypsin (alpha1AT) gene remains silent despite reactivation of the HNF4/HNF1alpha pathway in the M29 cells, the frequency of activation of an integrated alpha1AT-APRT transgene is increased 1000-fold in response to these transcription factors. The human alpha1AT locus (introduced via chromosome transfer) also remained silent on these cells, despite HNF4 and HNF1alpha expression. Results from cell fusion experiments suggest that the defect in the M29 cells is recessive. Results suggest that the M29 cells contain a defect that represses liver gene expression despite the presence of the HNF4/HNF1alpha pathway.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10540-005-2794-8DOI Listing

Publication Analysis

Top Keywords

m29 cells
12
hnf4 hnf1alpha
8
hnf1alpha expression
8
cell lines
8
hnf4/hnf1alpha pathway
8
cells
5
dissociation hepatic
4
hepatic phenotype
4
phenotype hnf4
4
expression
4

Similar Publications

Engineered aldoxime dehydratase to enable the chemoenzymatic conversion of benzyl amines to aromatic nitriles.

Bioorg Chem

May 2023

College of Material, Chemistry and Chemical Engineering, Key Laboratory of Organosilicon Chemistry and Material Technology of Ministry of Education, Hangzhou Normal University, 311121 Hangzhou, PR China. Electronic address:

A chemoenzymatic strategy has been implemented to synthesize nitriles from benzyl amines under mild conditions. Aldoxime dehydratase (Oxd) plays a decisive role to convert aldoximes into corresponding nitriles. However, natural Oxds commonly exhibit extremely low catalytic capacity toward benzaldehyde oximes.

View Article and Find Full Text PDF

OsMADS29 (M29) is a crucial regulator of seed development in rice. The expression of M29 is strictly regulated at transcriptional as well as post-transcriptional levels. The MADS-box proteins are known to bind to DNA as dimers.

View Article and Find Full Text PDF

MAK683 (-((5-fluoro-2,3-dihydrobenzofuran-4-yl)methyl)-8-(2-methylpyridin-3-yl)-[1,2,4]triazolo[4,3-]pyrimidin-5-amine) is a potent and orally bioavailable EED inhibitor for the potential treatment in oncology. Pharmacokinetics (PK) in preclinical species are characterised by low to moderate plasma clearances, high oral exposure, and moderate to high oral bioavailability at the dose of 1-2 mg/kg.A species comparison of the metabolic pathways of MAK683 has been made using [C]MAK683 incubations with liver microsomes and hepatocytes from rat, dog, cynomolgus monkey, and human.

View Article and Find Full Text PDF

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer.

Cancers (Basel)

July 2020

Research Department, Microenvironment Molecular Targets, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", 80131 Napoli, Italy.

The chemokine receptor CXCR4 is overexpressed and functional in colorectal cancer. To investigate the role of CXCR4 antagonism in potentiating colon cancer standard therapy, the new peptide CXCR4 antagonist Peptide R (Pep R) was employed. Human colon cancer HCT116 xenograft-bearing mice were treated with chemotherapeutic agents (CT) 5-Fluorouracil (5FU) and oxaliplatin (OX) or 5FU and radio chemotherapy (RT-CT) in the presence of Pep R.

View Article and Find Full Text PDF

An Ex Vivo Study to Evaluate the Effect of Tegaserod on Platelet Activation and Aggregation.

J Cardiovasc Pharmacol Ther

January 2021

Sinai Center for Thrombosis Research, 23303Sinai Hospital of Baltimore, LifeBridge Health, Baltimore, MD, USA.

Introduction: Tegaserod, an orally active, potent 5-hydroxytryptamine-4 serotonin receptor agonist, was previously indicated for irritable bowel syndrome but was voluntarily withdrawn due to potential cardiovascular side effects. In vitro studies suggested that tegaserod increased platelet aggregation, but these results were not reproduced or were inconclusive. We sought to assess ex vivo effects of tegaserod on platelet aggregation.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!